Viewing Study NCT06351527


Ignite Creation Date: 2026-03-26 @ 3:21 PM
Ignite Modification Date: 2026-04-01 @ 7:00 PM
Study NCT ID: NCT06351527
Status: RECRUITING
Last Update Posted: 2025-06-19
First Post: 2024-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
Sponsor: InnoCare Pharma Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module